AltPep logo

AltPep

AltPep is a Seattle-area biotech startup developing tests and treatments for Alzheimer’s and Parkinson’s disease, noted for promising...

Facts

HQ
University of Washington
Sectors
Biotechnology, Diagnostics, Therapeutics
Type
Corporation Seattle business license
Registered name
AltPep Corporation Seattle business license
Total raised
$69.6M SEC Form D filings Total of this company's SEC Form D filings
Last round
$44.4M · Jul 2022 SEC Form D

Recent coverage

Front-page news, podcasts and videos about AltPep

See all 6

AltPep Raises $52.9M to Advance Early Detection and Treatments for Alzheimer’s and Parkinson’s Diseases

AltPep, a University of Washington spinout developing tests and treatments for Alzheimer’s and Parkinson’s, raised $52.9 million in Series B funding to advance clinical trials and regulatory approval for its early detection blood test. The company targets toxic oligomers linked to Alzheimer’s and a related protein in Parkinson’s, aiming to enable early screening and preventive treatment.

People

  • Valerie Daggett
    Valerie Daggett Executive Officer, Director, Promoter, Founder and CEO

Online